Clinical and therapeutic features and prognostic factors of metastatic colorectal cancer over age 80: a retrospective study

por Hisada, Hiroyuki, Takahashi, Yu, Kubota, Manabu, Shimura, Haruhisa, Itobayashi, Ei, Shimura, Kenji, Nakamura, Akira
Publicado 2021

A feasibility study comparing gel immersion endoscopic resection and underwater endoscopic mucosal resection for superficial nonampullary duodenal epithelial tumors

por Miyakawa, Akihiro, Kuwai, Toshio, Sakuma, Yukie, Kubota, Manabu, Nakamura, Akira, Itobayashi, Ei, Shimura, Haruhisa, Suzuki, Yoshio, Shimura, Kenji
Publicado 2022

Role of hepatic resection in patients with intermediate‐stage hepatocellular carcinoma: A multicenter study from Japan

por Tada, Toshifumi, Kumada, Takashi, Toyoda, Hidenori, Tsuji, Kunihiko, Hiraoka, Atsushi, Itobayashi, Ei, Nouso, Kazuhiro, Kariyama, Kazuya, Ishikawa, Toru, Hirooka, Masashi, Hiasa, Yoichi
Publicado 2017

Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma

por Kariyama, Kazuya, Nouso, Kazuhiro, Toyoda, Hidenori, Tada, Toshifumi, Hiraoka, Atsushi, Tsuji, Kunihiko, Itobayashi, Ei, Ishikawa, Toru, Wakuta, Akiko, Oonishi, Ayano, Kumada, Takashi, Kudo, Masatoshi
Publicado 2019

Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality

por Hiraoka, Atsushi, Kumada, Takashi, Tada, Toshifumi, Toyoda, Hidenori, Kariyama, Kazuya, Hatanaka, Takeshi, Kakizaki, Satoru, Naganuma, Atsushi, Itobayashi, Ei, Tsuji, Kunihiko, Ishikawa, Toru, Ohama, Hideko, Tada, Fujimasa, Nouso, Kazuhiro
Publicado 2023

Clinical features of hemodialysis patients treated for hepatocellular carcinoma: Comparison between resection and radiofrequency ablation

por Hiraoka, Atsushi, Kumada, Takashi, Michitaka, Kojiro, Toyoda, Hidenori, Tada, Toshifumi, Takaguchi, Koichi, Tsuji, Kunihiko, Itobayashi, Ei, Takizawa, Daichi, Hirooka, Masashi, Koizumi, Yohei, Ochi, Hironori, Joko, Koji, Kisaka, Yoshiyasu, Shimizu, Yuko, Tajiri, Kazuto, Tani, Joji, Taniguchi, Tatsuya, Toshimori, Akiko, Fujioka, Shinichi
Publicado 2017

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis

por Hiraoka, Atsushi, Kumada, Takashi, Kariyama, Kazuya, Takaguchi, Koichi, Atsukawa, Masanori, Itobayashi, Ei, Tsuji, Kunihiko, Tajiri, Kazuto, Hirooka, Masashi, Shimada, Noritomo, Shibata, Hiroshi, Ishikawa, Toru, Ochi, Hironori, Tada, Toshifumi, Toyoda, Hidenori, Nouso, Kazuhiro, Tsutsui, Akemi, Itokawa, Norio, Imai, Michitaka, Joko, Kouji, Hiasa, Yoichi, Michitaka, Kojiro
Publicado 2018

Characteristics and Prognosis of De Novo Hepatocellular Carcinoma After Sustained Virologic Response

por Toyoda, Hidenori, Hiraoka, Atsushi, Uojima, Haruki, Nozaki, Akito, Shimada, Noritomo, Takaguchi, Koichi, Abe, Hiroshi, Atsukawa, Masanori, Matsuura, Kentaro, Ishikawa, Toru, Mikami, Shigeru, Watanabe, Tsunamasa, Itobayashi, Ei, Tsuji, Kunihiko, Arai, Taeang, Yasuda, Satoshi, Chuma, Makoto, Senoh, Tomonori, Tsutsui, Akemi, Okubo, Tomomi, Ehira, Takuya, Kumada, Takashi, Tanaka, Junko
Publicado 2021

The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan

por Hatanaka, Takeshi, Kakizaki, Satoru, Hiraoka, Atsushi, Kariyama, Kazuya, Tsuji, Kunihiko, Ishikawa, Toru, Toyoda, Hidenori, Yasuda, Satoshi, Naganuma, Atsushi, Tada, Toshifumi, Takaguchi, Koichi, Tsutsui, Akemi, Itobayashi, Ei, Shimada, Noritomo, Shibata, Hiroshi, Tanaka, Takaaki, Nagano, Takuya, Imai, Michitaka, Nakamura, Shinichiro, Nouso, Kazuhiro, Kosaka, Hisashi, Kaibori, Masaki, Kumada, Takashi
Publicado 2022

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis

por Hiraoka, Atsushi, Kumada, Takashi, Atsukawa, Masanori, Hirooka, Masashi, Tsuji, Kunihiko, Ishikawa, Toru, Takaguchi, Koichi, Kariyama, Kazuya, Itobayashi, Ei, Tajiri, Kazuto, Shimada, Noritomo, Shibata, Hiroshi, Ochi, Hironori, Tada, Toshifumi, Toyoda, Hidenori, Nouso, Kazuhiro, Tsutsui, Akemi, Nagano, Takuya, Itokawa, Norio, Hayama, Korenobu, Imai, Michitaka, Joko, Kouji, Koizumi, Yohei, Hiasa, Yoichi, Michitaka, Kojiro, Kudo, Masatoshi
Publicado 2019

Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study

por Tada, Toshifumi, Kumada, Takashi, Okushin, Hiroaki, Tani, Joji, Takaguchi, Koichi, Tsutsui, Akemi, Toyoda, Hidenori, Yasuda, Satoshi, Dohmen, Kazufumi, Hiraoka, Atsushi, Michitaka, Kojiro, Nouso, Kazuhiro, Kariyama, Kazuya, Kim, Soo Ryang, Kim, Soo Ki, Fujioka, Shinichi, Mikami, Shigeru, Watanabe, Yuto, Tamai, Tsutomu, Atsukawa, Masanori, Itokawa, Norio, Tanaka, Hironori, Tsuji, Kunihiko, Ishikawa, Toru, Imai, Michitaka, Itobayashi, Ei, Shibata, Hiroshi, Shimada, Noritomo
Publicado 2020

Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study

por Casadei-Gardini, Andrea, Rimini, Margherita, Kudo, Masatoshi, Shimose, Shigeo, Tada, Toshifumi, Suda, Goki, Goh, Myung Ji, Jefremow, Andre, Scartozzi, Mario, Cabibbo, Giuseppe, Campani, Claudia, Tamburini, Emiliano, Tovoli, Francesco, Ueshima, Kazuomi, Aoki, Tomoko, Iwamoto, Hideki, Torimura, Takuji, Kumada, Takashi, Hiraoka, Atsushi, Atsukawa, Masanori, Itobayashi, Ei, Toyoda, Hidenori, Sakamoto, Naoya, Sho, Takuya, Kang, Wonseok, Siebler, Jürgen, Neurath, Markus Friedrich, Burgio, Valentina, Cascinu, Stefano
Publicado 2022

Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma

por Kanogawa, Naoya, Ogasawara, Sadahisa, Maruta, Susumu, Iino, Yotaro, Obu, Masamichi, Ishino, Takamasa, Ogawa, Keita, Yumita, Sae, Iwanaga, Terunao, Unozawa, Hidemi, Nakagawa, Miyuki, Fujiwara, Kisako, Sakuma, Takafumi, Fujita, Naoto, Kojima, Ryuta, Kanzaki, Hiroaki, Koroki, Keisuke, Kobayashi, Kazufumi, Inoue, Masanori, Kiyono, Soichiro, Nakamura, Masato, Kondo, Takayuki, Saito, Tomoko, Nakagawa, Ryo, Nakamoto, Shingo, Muroyama, Ryosuke, Chiba, Tetsuhiro, Itobayashi, Ei, Koma, Yoshihiro, Azemoto, Ryosaku, Kato, Jun, Kato, Naoya
Publicado 2023

Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab

por Nouso, Kazuhiro, Shiota, Shohei, Fujita, Rio, Wakuta, Akiko, Kariyama, Kazuya, Hiraoka, Atsushi, Atsukawa, Masanori, Tani, Joji, Tada, Toshifumi, Nakamura, Shinichiro, Tajiri, Kazuto, Kaibori, Masaki, Hirooka, Masashi, Itobayashi, Ei, Kakizaki, Satoru, Naganuma, Atsushi, Ishikawa, Toru, Hatanaka, Takeshi, Fukunishi, Shinya, Tsuji, Kunihiko, Kawata, Kazuhito, Takaguchi, Koichi, Tsutsui, Akemi, Ogawa, Chikara, Ochi, Hironori, Yata, Yutaka, Kuroda, Hidekatsu, Iijima, Hiroko, Matono, Tomomitsu, Shimada, Noritomo, Yasuda, Satoshi, Toyoda, Hidenori, Kumada, Takashi
Publicado 2023

Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma

por Hiraoka, Atsushi, Kumada, Takashi, Tada, Toshifumi, Ogawa, Chikara, Tani, Joji, Fukunishi, Shinya, Atsukawa, Masanori, Hirooka, Masashi, Tsuji, Kunihiko, Ishikawa, Toru, Takaguchi, Koichi, Kariyama, Kazuya, Itobayashi, Ei, Tajiri, Kazuto, Shimada, Noritomo, Shibata, Hiroshi, Ochi, Hironori, Kawata, Kazuhito, Toyoda, Hidenori, Ohama, Hideko, Nouso, Kazuhiro, Tsutsui, Akemi, Nagano, Takuya, Itokawa, Norio, Hayama, Korenobu, Arai, Taeang, Imai, Michitaka, Koizumi, Yohei, Nakamura, Shinichiro, Michitaka, Kojiro, Hiasa, Yoichi, Kudo, Masatoshi
Publicado 2020

Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib

por Tada, Toshifumi, Kumada, Takashi, Hiraoka, Atsushi, Atsukawa, Masanori, Hirooka, Masashi, Tsuji, Kunihiko, Ishikawa, Toru, Takaguchi, Koichi, Kariyama, Kazuya, Itobayashi, Ei, Tajiri, Kazuto, Shimada, Noritomo, Shibata, Hiroshi, Ochi, Hironori, Yasuda, Satoshi, Toyoda, Hidenori, Fukunishi, Shinya, Ohama, Hideko, Kawata, Kazuhito, Tani, Joji, Nakamura, Shinichiro, Nouso, Kazuhiro, Tsutsui, Akemi, Nagano, Takuya, Takaaki, Tanaka, Itokawa, Norio, Okubo, Tomomi, Arai, Taeang, Imai, Michitaka, Joko, Kouji, Koizumi, Yohei, Hiasa, Yoichi
Publicado 2021

Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting

por Hiraoka, Atsushi, Kumada, Takashi, Kariyama, Kazuya, Tada, Toshifumi, Tani, Joji, Fukunishi, Shinya, Atsukawa, Masanori, Hirooka, Masashi, Tsuji, Kunihiko, Ishikawa, Toru, Takaguchi, Koichi, Itobayashi, Ei, Tajiri, Kazuto, Shimada, Noritomo, Shibata, Hiroshi, Ochi, Hironori, Kawata, Kazuhito, Yasuda, Satoshi, Toyoda, Hidenori, Ohama, Hideko, Nouso, Kazuhiro, Tsutsui, Akemi, Nagano, Takuya, Itokawa, Norio, Hayama, Korenobu, Arai, Taeang, Imai, Michitaka, Koizumi, Yohei, Nakamura, Shinichiro, Joko, Kouji, Michitaka, Kojiro, Hiasa, Yoichi, Kudo, Masatoshi
Publicado 2020

Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study

por Hiraoka, Atsushi, Kumada, Takashi, Tada, Toshifumi, Tani, Joji, Kariyama, Kazuya, Fukunishi, Shinya, Atsukawa, Masanori, Hirooka, Masashi, Tsuji, Kunihiko, Ishikawa, Toru, Takaguchi, Koichi, Itobayashi, Ei, Tajiri, Kazuto, Shimada, Noritomo, Shibata, Hiroshi, Ochi, Hironori, Kawata, Kazuhito, Yasuda, Satoshi, Toyoda, Hidenori, Aoki, Tomoko, Tanaka, Takaaki, Ohama, Hideko, Nouso, Kazuhiro, Tsutsui, Akemi, Nagano, Takuya, Itokawa, Norio, Arai, Taeang, Okubo, Tomomi, Imai, Michitaka, Koizumi, Yohei, Nakamura, Shinichiro, Joko, Koji, Hiasa, Yoichi, Kudo, Masatoshi
Publicado 2021

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience

por Hiraoka, Atsushi, Kumada, Takashi, Tada, Toshifumi, Hirooka, Masashi, Kariyama, Kazuya, Tani, Joji, Atsukawa, Masanori, Takaguchi, Koichi, Itobayashi, Ei, Fukunishi, Shinya, Tsuji, Kunihiko, Ishikawa, Toru, Tajiri, Kazuto, Ochi, Hironori, Yasuda, Satoshi, Toyoda, Hidenori, Ogawa, Chikara, Nishimura, Takashi, Hatanaka, Takeshi, Ohama, Hideko, Nouso, Kazuhiro, Morishita, Asahiro, Tsutsui, Akemi, Nagano, Takuya, Itokawa, Norio, Okubo, Tomomi, Arai, Taeang, Imai, Michitaka, Koizumi, Yohei, Nakamura, Shinichiro, Joko, Kouji, Iijima, Hiroko, Hiasa, Yoichi, Kudo, Masatoshi
Publicado 2021

C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib

por Tada, Toshifumi, Kumada, Takashi, Hiraoka, Atsushi, Hirooka, Masashi, Kariyama, Kazuya, Tani, Joji, Atsukawa, Masanori, Takaguchi, Koichi, Itobayashi, Ei, Fukunishi, Shinya, Tsuji, Kunihiko, Ishikawa, Toru, Tajiri, Kazuto, Ochi, Hironori, Yasuda, Satoshi, Toyoda, Hidenori, Hatanaka, Takeshi, Kakizaki, Satoru, Shimada, Noritomo, Kawata, Kazuhito, Tanaka, Takaaki, Ohama, Hideko, Nouso, Kazuhiro, Morishita, Asahiro, Tsutsui, Akemi, Nagano, Takuya, Itokawa, Norio, Okubo, Tomomi, Arai, Taeang, Imai, Michitaka, Naganuma, Atsushi, Aoki, Tomoko, Koizumi, Yohei, Nakamura, Shinichiro, Joko, Kouji, Hiasa, Yoichi, Kudo, Masatoshi
Publicado 2022